Search for: "Teva Pharmaceuticals"
Results 1341 - 1360
of 1,430
Sorted by Relevance
|
Sort by Date
17 Mar 2014, 5:13 pm
Teva Pharmaceuticals USA, Inc., 619 F.3d 1329 (Fed. [read post]
7 Dec 2023, 1:47 pm
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and… [read post]
12 Sep 2022, 9:01 pm
Securities Class Action Settlements The Twitter settlement ranks number two in 2022 in terms of the largest worldwide settlement (trailing only the €1.4 billion Steinhoff International case that resolved concurrently in the Netherlands and South Africa), however it significantly exceeds the other top U.S. settlements of 2022, which are: Teva Pharmaceutical Industries Ltd. [read post]
7 Jun 2011, 12:30 pm
Teva Pharmaceuticals USADocket: 10-1070Issue(s): When a case becomes moot as the result of a third party’s independent action after the court of appeals issues a judgment but while a petition for rehearing is still pending, should the court of appeals vacate the judgment upon the request of the aggrieved party? [read post]
25 May 2011, 8:52 pm
From the pharmaceutical industry, amicus briefs were filed by Apotex; Sanofi-Aventis; Eli Lilly & Co.; BIO; Eisai; Johnson & Johnson; PhRMA; Teva; and GPhA. [read post]
12 Jun 2023, 1:09 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
22 Feb 2008, 6:00 pm
), (Washington State Patent Law Blog), (The IP Factor), (IPBiz), (IP Spotlight), (IP Law360), (Innovationpartners), (IPBiz),US FTC files complaint against Cephalon alleging the company paid four generic drug manufacturers (Ranbaxy, Teva, Mylan and Barr) to delay entry as part of litigation settlements: (IP Law360), (IP Law360), (Spicy IP),GlobalGlobal - GeneralWhat is IP value all about? [read post]
25 Jun 2014, 2:00 pm
Teva Pharmaceuticals USA, Inc. v. [read post]
5 Apr 2012, 11:54 am
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734, at *3 (S.D. [read post]
11 Aug 2017, 9:09 am
Teva Pharmaceuticals, suggests the court will not impose a secret commercial use or secret sale exception to the public use and on sale bars.[26] In Helsinn Healthcare, the Federal Circuit recognized that “such floor statements are typically not reliable indicators of congressional intent. [read post]
5 Aug 2024, 10:17 am
Teva Pharmaceuticals USA, Inc., 586 U.S. 123 (2019), the Supreme Court held that a commercial sale to a third party may place the invention “on sale” under § 102(a)(1), even if the sale does not disclose the details of the invention to the public. [read post]
18 Jul 2014, 11:55 am
Teva Pharmaceuticals USA, Inc., 2010 WL 2640170, at *2 (W.D. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real… [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
2 Feb 2015, 2:20 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) reports on the Hague Court of Appeal’s summary ruling in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
23 Dec 2020, 5:31 am
In Teva v Chiesi [2020] EWHC 1311 (Pat), the defendants sought to strike out an infringement claim on that basis that a market authorisation was a prerequisite for a quia timet infringement action. [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
31 Dec 2014, 5:00 am
Xanodyne Pharmaceuticals, Inc., 771 F.3d 1218 (9th Cir. 2014) (en banc). [read post]
16 Nov 2009, 4:51 am
(Class 99) United States US General Wisconsin judge vacates $ 1.26 billion judgment in default against PepsiCo (IPKat) (IP Factor) California Court of Appeal: Von Dutch tradename settlement gives rise to legal malpractice action and questionable mediation confidentiality decision: Michael Cassel v Superior Court of Los Angeles County (The IP ADR Blog) US Patent Reform Putting the USPTO to work for independent inventors (Director's Forum) (Inventive Step) (IP Asset Maximizer Blog)… [read post]
